Literature DB >> 8614598

The hemolytic uremic syndrome.

R L Siegler1.   

Abstract

HUS is the most common cause of acute renal failure in infants and young children and follows a diarrheal prodrome about 90% of the time. Persuasive evidence shows that virtually all of postdiarrheal cases are caused by EHEC infections, and that the great majority of cases in the United States are caused by the EHEC serotype O157:H7. Mortality is approximately 5%, and approximately 10% of survivors are left with severe sequelae. A much larger number (30%-50%) experience mild chronic renal damage. Public health strategies, including zero tolerance for fecal contamination in slaughter houses and additional public education on proper food handling and cooking, does much to decrease the prevalence of the syndrome. Efforts to further dissect the postdiarrheal pathogenic cascade should continue, and an animal model needs to be developed. Only then will researchers be positioned to develop effective intervention strategies. Preventing life-threatening extrarenal complications, especially of the CNS, is a major challenge. Idiopathic nondiarrheal HUS accounts for approximately 10% of cases and comprises a poorly understood composite of HUS subsets. Research directed toward a better understanding of these mysterious variants also is a priority for the years ahead.

Entities:  

Mesh:

Year:  1995        PMID: 8614598     DOI: 10.1016/s0031-3955(16)40096-9

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  37 in total

Review 1.  Alternative sigma factors and their roles in bacterial virulence.

Authors:  Mark J Kazmierczak; Martin Wiedmann; Kathryn J Boor
Journal:  Microbiol Mol Biol Rev       Date:  2005-12       Impact factor: 11.056

2.  Shiga toxin-1 affects nitric oxide production by human glomerular endothelial and mesangial cells.

Authors:  D Maroeska Te Loo; Leo Monnens; Thea van der Velden; Mohammed Karmali; Lambertus van den Heuvel; Victor van Hinsbergh
Journal:  Pediatr Nephrol       Date:  2006-08-30       Impact factor: 3.714

3.  Public health implications of a case of haemolytic-uraemic syndrome associated with a concomitant outbreak of mild gastroenteritis in a small rural community.

Authors:  L Busani; D Boccia; A Caprioli; F M Ruggeri; S Morabito; F Minelli; S Lana; G Rizzoni; F Giofrè; M Mazzeo; A E Tozzi
Journal:  Epidemiol Infect       Date:  2006-04       Impact factor: 2.451

4.  Construction and characterization of an isogenic slt-ii deletion mutant of enterohemorrhagic Escherichia coli.

Authors:  F Gunzer; U Bohn; S Fuchs; I Mühldorfer; J Hacker; S Tzipori; A Donohue-Rolfe
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

5.  Hemolytic uremic syndrome associated with group A beta-hemolytic streptococcus.

Authors:  Amy B Shepherd; April L Palmer; Steven A Bigler; Radhakrishna Baliga
Journal:  Pediatr Nephrol       Date:  2003-06-26       Impact factor: 3.714

6.  Peripheral gangrene complicating hemolytic uremic syndrome in a child.

Authors:  Ahmet Ozel; Umran Calişkan; Safak Gücer
Journal:  Pediatr Nephrol       Date:  2003-03-28       Impact factor: 3.714

7.  Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome.

Authors:  Richard L Siegler; Tom G Obrig; Theodore J Pysher; Vernon L Tesh; Nathaniel D Denkers; Fletcher B Taylor
Journal:  Pediatr Nephrol       Date:  2003-01-10       Impact factor: 3.714

8.  In silico genomic analyses reveal three distinct lineages of Escherichia coli O157:H7, one of which is associated with hyper-virulence.

Authors:  Chad R Laing; Cody Buchanan; Eduardo N Taboada; Yongxiang Zhang; Mohamed A Karmali; James E Thomas; Victor Pj Gannon
Journal:  BMC Genomics       Date:  2009-06-29       Impact factor: 3.969

9.  Regulation of proinflammatory cytokine expression by Shiga toxin 1 and/or lipopolysaccharides in the human monocytic cell line THP-1.

Authors:  Lisa M Harrison; Wilhelmina C E van Haaften; Vernon L Tesh
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

10.  Elevated levels of vascular endothelial growth factor in serum of patients with D+ HUS.

Authors:  D Maroeska Te Loo; Nienke Bosma; Victor Van Hinsbergh; Paul Span; Rob De Waal; Ruud Clarijs; C Sweep; Leo Monnens; Lambertus Van Den Heuvel
Journal:  Pediatr Nephrol       Date:  2004-05-13       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.